LicianPro

Eric Sheridan

Equity research analyst · Goldman Sachs

Earnings calls

4

Nov 4, 2026 – Nov 4, 2026

Stocks asked about

4

Questions

5

Firm rating actions

0

on these stocks, from news

Coverage

Companies whose earnings calls Eric Sheridan asked questions on (from Lician's transcripts).

Questions on earnings calls

  1. ANGI earnings call · Angi Inc.Nov 4, 2026 · 1 question
    • 28:03
      “Maybe two following up on the prepared marks. With respect to the cost savings you mentioned, is there a way to conceptualize or quantify the mix between cost saved dropping into margin and free cash flow relative to what needs to be reinvested? And maybe the broader question…”
    • 16:25
      “Thanks so much.”
  2. SNAP earnings call · Snap IncNov 4, 2026 · 1 question
    • 19:45
      “Maybe two if I could. I want to come back to the audience metric shift towards MAU and understand a little bit better just the thought process. around that and how that's the indication you want to leave folks with in terms of measuring the business going forward. And then the…”
  3. YOU earnings call · Clear Secure, Inc.Nov 4, 2026 · 2 questions
    • 15:29
      “I wanted to start on CLEAR+. How are you thinking about some of the learnings about the scaling of CLEAR+, and what it sort of translates into in terms of a long-term view of what the scope of the opportunity is, whether you're measured by CLEAR+.”
    • 20:54
      “If we look at the clear one pipeline for Q4, last year in Q4, the clear one business really accelerated, including the CMS deal. And you had a very strong quarter, which we presume sets up a difficult comparison for Q4. How are you thinking about that dynamic as you set bookings…”

Quotes are machine transcriptions of the official webcast (Whisper) and may contain errors; the timestamp opens the call at that moment.

Goldman Sachs rating actions on these stocks

From news headlines Lician stores, each linked to its source. A headline names the firm; it may not name Eric Sheridan. We do not use licensed rating databases.

No rating action by Goldman Sachs on these stocks in the headlines we store yet.